This Termite Killer's Stock Is AI-Proof. Shares Can Keep Moving Up, JPMorgan Says. -- Barrons.com

Dow Jones
09/27

By Paul R. La Monica

Artificial intelligence chatbots might be able to give you some decent tips on how to get rid of termites, ants, and other pesky creatures, but at the end of the day, it's probably best to call a professional. That's one reason why Rollins -- which owns Orkin, HomeTeam Pest Defense, Critter Control and several other exterminator brands -- has been a solid stock this year.

Shares of Rollins are up more than 25% in 2025, and an analyst at JPMorgan thinks there is more upside ahead -- mainly because it is an AI-proof stock. JPMorgan's Tomohiko Sano launched coverage of Rollins Friday with an Overweight rating -- basically a Buy -- and a price target of $70 a share. That's more than 20% above the stock's current price. Shares rose 3% Friday.

If anything, AI and other technological advances will help Rollins as opposed to it, Sano thinks.

"Digital tools are being rolled out across the network, including technician apps, route optimization, paperless contracts, and sales enablement platforms," Sano wrote, adding that "management views digitization not as a substitute for people but as an enabler that improves productivity, consistency, and customer experience while supporting the frontline workforce."

Investors need to be prepared to pay a lofty premium for the stock, though. Rollins trades at nearly 47 times earnings estimates for 2026, compared to a price-to-earnings ratio of 32 for rival Ecolab and a multiple of just 17 for competitor Rentokil, which owns Terminix. Still, Rollins is trading right around its 5-year average forward P/E -- so it's not looking stretched. And Sano thinks the premium is worth it.

He noted that Rollins has "maintained a clear valuation premium over its competitors, Rentokil and Ecolab, reflecting its strong operational track record and consistent financial performance," adding that the "multiple has remained notably higher than both peers, indicating sustained investor confidence in its business model and growth prospects."

"The company's ability to deliver stable results and navigate market challenges has set it apart within the sector. Rollins' superior valuation underscores its position as a leader in operational efficiency, " Sano wrote.

The rest of Wall Street is a little less certain that Rollins should trade at such a high valuation. According to FactSet, 47% of the analysts covering Rollins recommend it as a Buy, while another 47% rate it a Hold and the remaining 6% think it's a Sell. The consensus price target of $61 is just 3% above current levels. Analysts are forecasting annual earnings increases in the low-to-mid-teens for the next few years.

For what it's worth, Warren Buffett is a fan of the pest control business, too. Berkshire Hathaway recently bought a privately held pest control company named Bell Laboratories -- not to be confused with the famous telecom research outfit Bell Labs that is now owned by Nokia.

So the combination of Buffett's endorsement of the industry and the fact that AI won't make exterminating pests obsolete should mean that shares of Rollins won't get stuck in place like a rat in a glue trap.

Write to Paul R. La Monica at paul.lamonica@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

September 26, 2025 14:49 ET (18:49 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10